Cash flow HeartFlow, Inc.

Stocks

HTFL

US42238D1072

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 18:06:59 20/07/2026 BST			5-day change	1st Jan Change
24.40 ^USD	-1.93%		-7.03%	-16.57%

07-09	Heartflow to Announce Eight New Datasets from Clinical Studies Spanning More Than 36,000 Patients at the Society of Cardiovascular Computed Tomography	CI
06-29	HeartFlow, Inc.(NasdaqGS:HTFL) dropped from Russell Small Cap Comp Value Benchmark	CI

bd03283f9b25140.bghB4UbV-2bZXTPZlTmgcfijBHHLznxhflUs1g6Ysaw.B2pyzHfkkDy1J3Gu0WzTHKzLdheZng0TFD9Ljlvy4fVDbnKjDYCkUaspcg

Published financial data: HEARTFLOW, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2023	2024	2025
Revenues	87.17M	126M	176M
Total Revenues	87.17M	126M	176M
Cost of Goods Sold, Total	29.12M	31.36M	40.84M
Gross Profit	58.05M	94.45M	135M
Selling General & Admin Expenses, Total	95.11M	112M	134M
R&D Expenses	35.85M	43.52M	64.92M
Other Operating Expenses, Total	131M	156M	199M
Operating Income	-72.91M	-61.22M	-64.07M
Interest Expense, Total	-24.69M	-22.77M	-15.17M
Interest And Investment Income	5.46M	4.07M	5.54M
Net Interest Expenses	-19.24M	-18.7M	-9.64M
Currency Exchange Gains (Loss)	-	-	-25K
Other Non Operating Income (Expenses)	2.16M	-16.45M	-36.78M
EBT, Excl. Unusual Items	-89.99M	-96.37M	-111M
Other Unusual Items	-5.12M	-	-6.36M
EBT, Incl. Unusual Items	-95.11M	-96.37M	-117M
Income Tax Expense	547K	53K	-76K
Earnings From Continuing Operations	-95.66M	-96.43M	-117M
Net Income to Company	-95.66M	-96.43M	-117M
Net Income - (IS)	-95.66M	-96.43M	-117M
Preferred Dividend and Other Adjustments	28.03M	-	-
Net Income to Common Incl Extra Items	-124M	-96.43M	-117M
Net Income to Common Excl. Extra Items	-124M	-96.43M	-117M
Per Share Items
Net EPS - Basic	-25.32	-17.98	-3.17
Basic EPS - Continuing Operations	-25.32	-17.98	-3.17
Basic Weighted Average Shares Outstanding	4.89M	5.36M	36.85M
Net EPS - Diluted	-25.32	-17.98	-3.17
Diluted EPS - Continuing Operations	-25.32	-17.98	-3.17
Diluted Weighted Average Shares Outstanding	4.89M	5.36M	36.85M
Normalized Basic EPS	-11.51	-11.23	-1.87
Normalized Diluted EPS	-11.51	-11.23	-1.87
Supplemental Items
EBITDA	-71.37M	-59.56M	-62.63M
EBITA	-72.91M	-61.22M	-64.07M
EBIT	-72.91M	-61.22M	-64.07M
EBITDAR	-65.34M	-53.07M	-56.13M
Effective Tax Rate - (Ratio)	-0.58	-0.05	0.06
Normalized Net Income	-56.24M	-60.23M	-69.07M
Supplemental Operating Expense Items
Advertising Expense	778K	1.54M	2M
Research And Development Expense From Footnotes	35.85M	43.52M	64.92M
Net Rental Expense, Total	6.03M	6.5M	6.5M
Imputed Operating Lease Interest Expense	-	7.37M	8.65M
Imputed Operating Lease Depreciation	-	-876K	-2.15M
Stock-Based Comp., COGS (Total)	440K	307K	413K
Stock-Based Comp., R&D Exp. (Total)	3.34M	2.15M	3.43M
Stock-Based Comp., SG&A Exp. (Total)	8.72M	7.76M	10.12M
Total Stock-Based Compensation	12.5M	10.21M	13.96M

Fiscal Period: December	2023	2024	2025
Assets
Cash And Equivalents	123M	51.37M	44.78M
Short Term Investments	-	-	132M
Total Cash And Short Term Investments	123M	51.37M	177M
Accounts Receivable, Total	22.5M	27.09M	29.34M
Total Receivables	22.5M	27.09M	29.34M
Prepaid Expenses	3.18M	3.02M	5.96M
Restricted Cash	-	150K	-
Other Current Assets, Total	-	662K	8.11M
Total Current Assets	148M	82.29M	220M
Gross Property Plant And Equipment	81.55M	79.22M	38.58M
Accumulated Depreciation	-50.66M	-51.49M	-12.5M
Net Property Plant And Equipment	30.88M	27.72M	26.08M
Long-term Investments	-	-	103M
Accounts Receivable Long-Term	988K	3.7M	-
Deferred Charges Long-Term	-	413K	4.26M
Other Long-Term Assets, Total	4.73M	4.58M	5.55M
Total Assets	185M	119M	359M
Liabilities
Accounts Payable, Total	2.89M	2.87M	3.17M
Accrued Expenses, Total	19.17M	21.83M	30.73M
Current Portion of Leases	5.14M	5.42M	5.92M
Unearned Revenue Current, Total	2.11M	1.04M	627K
Other Current Liabilities	3.51M	2.45M	1.93M
Total Current Liabilities	32.82M	33.6M	42.37M
Long-Term Debt	134M	136M	-
Long-Term Leases	21.45M	18.54M	16.13M
Other Non Current Liabilities	5.77M	21.05M	303K
Total Liabilities	194M	210M	58.8M
Preferred Stock Convertible	769M	769M	-
Total Preferred Equity	769M	769M	-
Common Stock, Total	14K	18K	85K
Additional Paid In Capital	97.46M	112M	1.39B
Retained Earnings	-875M	-971M	-1.09B
Comprehensive Income and Other	-501K	-772K	-425K
Total Common Equity	-778M	-859M	301M
Total Equity	-9M	-90.92M	301M
Total Liabilities And Equity	185M	119M	359M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.94M	6.12M	85.76M
ECS Total Common Shares Outstanding	4.94M	6.12M	85.28M
Book Value / Share	-157.37	-140.39	3.53
Tangible Book Value	-778M	-859M	301M
Tangible Book Value Per Share	-157.37	-140.39	3.53
Total Debt	161M	160M	22.05M
Net Debt	37.83M	109M	-155M
Debt Equivalent Oper. Leases	48.21M	51.98M	51.98M
Account Code - Inventory Valuation	3	3	3
Machinery, Total	9.94M	5.72M	6.34M
Full Time Employees	-	626	843
Accumulated Allowance for Doubtful Accounts (Supple)	1.06M	814K	626K

Fiscal Period: December	2023	2024	2025
Net Income	-95.66M	-96.43M	-117M
Depreciation & Amortization - CF	4.43M	4.39M	4.57M
Depreciation & Amortization, Total	4.43M	4.39M	4.57M
Amortization of Deferred Charges, Total - (CF)	6.84M	5.31M	9.37M
(Gain) Loss on Sale of Investments - (CF)	-	-	-1.68M
Stock-Based Compensation (CF)	11.87M	10.21M	13.96M
Provision and Write-off of Bad Debts	1.19M	-244K	188K
Other Operating Activities, Total	144K	18.63M	44.01M
Change In Accounts Receivable	-9.35M	-3.85M	-4.89M
Change In Accounts Payable	-623K	-327K	218K
Change in Other Net Operating Assets	4.71M	-6.7M	-2.99M
Cash from Operations	-76.43M	-69M	-54.02M
Capital Expenditure	-6.1M	-4.36M	-5.02M
Investment in Marketable and Equity Securities, Total	-	-	-234M
Cash from Investing	-6.1M	-4.36M	-239M
Long-Term Debt Issued, Total	-	-	72.77M
Total Debt Issued	-	-	72.77M
Long-Term Debt Repaid, Total	-	-	-115M
Total Debt Repaid	-	-	-115M
Issuance of Common Stock	589K	4.56M	336M
Repurchase of Common Stock	-228K	-	-510K
Issuance of Preferred Stock	169M	-	-
Other Financing Activities, Total	-	-2.33M	-6.76M
Cash from Financing	169M	2.24M	286M
Foreign Exchange Rate Adjustments	-504K	-271K	191K
Net Change in Cash	86.28M	-71.39M	-6.36M
Supplemental Items
Cash Interest Paid	20.8M	19.16M	8.57M
Cash Income Tax Paid (Refund)	405K	-72K	-
Levered Free Cash Flow	-	-41.66M	-30.88M
Unlevered Free Cash Flow	-	-29.04M	-26.77M
Change In Net Working Capital	-	4.73M	4.24M
Net Debt Issued / Repaid	-	-	-42.37M

Fiscal Period: December	2023	2024	2025
Profitability
Return on Assets	-	-25.19	-16.75
Return on Total Capital	-	-34.62	-20.42
Return On Equity %	-	193.01	-111.37
Return on Common Equity	-	11.78	41.8
Margin Analysis
Gross Profit Margin %	66.59	75.07	76.8
SG&A Margin	109.1	89.15	76.32
EBITDA Margin %	-81.87	-47.35	-35.58
EBITA Margin %	-83.64	-48.66	-36.39
EBIT Margin %	-83.64	-48.66	-36.39
Income From Continuing Operations Margin %	-109.73	-76.65	-66.35
Net Income Margin %	-109.73	-76.65	-66.35
Net Avail. For Common Margin %	-141.89	-76.65	-66.35
Normalized Net Income Margin	-64.52	-47.88	-39.23
Levered Free Cash Flow Margin	-	-33.12	-17.54
Unlevered Free Cash Flow Margin	-	-23.09	-15.21
Asset Turnover
Asset Turnover	-	0.83	0.74
Fixed Assets Turnover	-	4.29	6.54
Receivables Turnover (Average Receivables)	-	5.07	6.52
Short Term Liquidity
Current Ratio	4.52	2.45	5.2
Quick Ratio	4.43	2.33	4.86
Operating Cash Flow to Current Liabilities	-2.33	-2.05	-1.28
Days Sales Outstanding (Average Receivables)	-	72.13	55.96
Average Days Payable Outstanding	-	33.6	26.99
Long Term Solvency
Total Debt/Equity	-1.78K	-176.41	7.34
Total Debt / Total Capital	105.94	230.88	6.83
LT Debt/Equity	-1.73K	-170.45	5.37
Long-Term Debt / Total Capital	102.55	223.08	5
Total Liabilities / Total Assets	104.86	176.59	16.36
EBIT / Interest Expense	-2.95	-2.69	-4.22
EBITDA / Interest Expense	-2.65	-2.33	-3.7
(EBITDA - Capex) / Interest Expense	-2.89	-2.52	-4.03
Total Debt / EBITDA	-2.46	-3.02	-0.39
Net Debt / EBITDA	-0.58	-2.05	2.76
Total Debt / (EBITDA - Capex)	-2.25	-2.79	-0.36
Net Debt / (EBITDA - Capex)	-0.53	-1.9	2.53
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	44.32	39.92
Gross Profit, 1 Yr. Growth %	-	62.7	43.14
EBITDA, 1 Yr. Growth %	-	-16.54	5.14
EBITA, 1 Yr. Growth %	-	-16.04	4.65
EBIT, 1 Yr. Growth %	-	-16.04	4.65
Earnings From Cont. Operations, 1 Yr. Growth %	-	0.81	21.12
Net Income, 1 Yr. Growth %	-	0.81	21.12
Normalized Net Income, 1 Yr. Growth %	-	7.1	14.67
Diluted EPS Before Extra, 1 Yr. Growth %	-	-28.99	-82.37
Accounts Receivable, 1 Yr. Growth %	-	20.41	19.09
Net Property, Plant and Equip., 1 Yr. Growth %	-	-10.22	-5.95
Total Assets, 1 Yr. Growth %	-	-35.85	202.81
Tangible Book Value, 1 Yr. Growth %	-	10.54	-134.98
Common Equity, 1 Yr. Growth %	-	10.54	-134.98
Cash From Operations, 1 Yr. Growth %	-	-9.72	-21.71
Capital Expenditures, 1 Yr. Growth %	-	-28.63	15.33
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-25.88
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-7.84
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	42.1
Gross Profit, 2 Yr. CAGR %	-	-	52.61
EBITDA, 2 Yr. CAGR %	-	-	-6.33
EBITA, 2 Yr. CAGR %	-	-	-6.26
EBIT, 2 Yr. CAGR %	-	-	-6.26
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	10.5
Net Income, 2 Yr. CAGR %	-	-	10.5
Normalized Net Income, 2 Yr. CAGR %	-	-	10.82
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-64.62
Accounts Receivable, 2 Yr. CAGR %	-	-	14.2
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-8.11
Total Assets, 2 Yr. CAGR %	-	-	39.37
Tangible Book Value, 2 Yr. CAGR %	-	-	-37.82
Common Equity, 2 Yr. CAGR %	-	-	-37.82
Cash From Operations, 2 Yr. CAGR %	-	-	-15.93
Capital Expenditures, 2 Yr. CAGR %	-	-	-9.28